GENE ONLINE|News &
Opinion
Blog

Merck
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Merck’s Streptococcus pneumoniae Expansion Finally Receives European Commission Approval
2022-10-24
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
1 2 3 7
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top